Differences in Response to Recombinant Growth Hormone Therapy on Height Gain in Patients with Idiopathic Short Stature Vs. Patients with Growth Hormone Deficiency

Objective The use of recombinant human growth hormone (rhGH) in patients with idiopathic short stature (ISS) has been an area of concern since some studies reported less desired effects of the drug in this group of patients as compared to patients with growth hormone deficiency (GHD). In addition, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Alzahrani, Ali K, Algethami, Abdulmohsin K, Barnawi, Ghassan, Meftah, Ibraheem A, Alshanqiti, Ammar, Al-Hashmi, Hashim, Khan, Mohammed A, Felimban, Nailah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164722/
https://www.ncbi.nlm.nih.gov/pubmed/32313760
http://dx.doi.org/10.7759/cureus.7319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164722/
https://www.ncbi.nlm.nih.gov/pubmed/32313760
http://dx.doi.org/10.7759/cureus.7319

Ejemplares similares